pyrroles and dm 232
pyrroles has been researched along with dm 232 in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bartolini, A; Bellucci, C; Dei, S; Galeotti, N; Ghelardini, C; Gualtieri, F; Manetti, D; Romanelli, MN; Scapecchi, S; Teodori, E | 1 |
| Bartolini, A; Galeotti, N; Ghelardini, C; Gualtieri, F; Manetti, D; Pittaluga, A; Pugliese, AM; Romanelli, MN | 1 |
| Dei, S; Galeotti, N; Ghelardini, C; Guandalini, L; Manetti, D; Martelli, C; Martini, E; Novella Romanelli, M; Scapecchi, S; Teodori, E | 1 |
| Bertucci, C; Dei, S; Ghelardini, C; Gualtieri, F; Guandalini, L; Manetti, D; Martini, E; Romanelli, MN; Scapecchi, S; Teodori, E | 1 |
| Galeotti, N; Ghelardini, C; Gualtieri, F; Manetti, D; Martini, E; Romanelli, MN | 1 |
| Dei, S; Ghelardini, C; Guandalini, L; Manetti, D; Martini, E; Melchiorre, M; Norcini, M; Pagella, S; Romanelli, MN; Scapecchi, S; Teodori, E | 1 |
| Bartolucci, G; Dei, S; Di Cesare Mannelli, L; Floriddia, E; Ghelardini, C; Guandalini, L; Malik, R; Manetti, D; Martino, MV; Melani, F; Orlandi, F; Romanelli, MN; Teodori, E | 1 |
| Gualtieri, F | 1 |
Reviews
2 review(s) available for pyrroles and dm 232
| Article | Year |
|---|---|
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers.
Topics: Animals; Central Nervous System; Cognition; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Nootropic Agents; Piperazines; Pyrroles; Synaptic Transmission | 2006 |
Unifi nootropics from the lab to the web: a story of academic (and industrial) shortcomings.
Topics: Animals; Cognition; Drug Evaluation, Preclinical; Humans; Internet; Nootropic Agents; Patents as Topic; Piperazines; Pyrroles; Structure-Activity Relationship | 2016 |
Other Studies
6 other study(ies) available for pyrroles and dm 232
| Article | Year |
|---|---|
Design, synthesis, and preliminary pharmacological evaluation of 1, 4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents.
Topics: Adrenergic alpha-Agonists; Amnesia; Animals; Avoidance Learning; Baclofen; Clonidine; Dose-Response Relationship, Drug; Drug Design; GABA Agonists; Mecamylamine; Mice; Molecular Structure; Muscarinic Antagonists; Nicotine; Nootropic Agents; Piperazines; Piracetam; Pyrroles; Scopolamine | 2000 |
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram).
Topics: Amnesia; Animals; Avoidance Learning; Cognition; Dose-Response Relationship, Drug; Electrophysiology; Hippocampus; Kynurenic Acid; Male; Mice; N-Methylaspartate; Nootropic Agents; Piperazines; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 2003 |
Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs.
Topics: Animals; Avoidance Learning; Dose-Response Relationship, Drug; Mice; Nootropic Agents; Pain Measurement; Pain Threshold; Piperazines; Pyrroles; Rats; Structure-Activity Relationship | 2004 |
Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent.
Topics: Animals; Avoidance Learning; Dose-Response Relationship, Drug; Male; Mice; Molecular Structure; Nootropic Agents; Piperazines; Pyrroles; Rats; Rats, Wistar; Stereoisomerism | 2005 |
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators.
Topics: Animals; Avoidance Learning; Data Interpretation, Statistical; Drug Design; Mice; Nootropic Agents; Piperazines; Pyrroles; Recognition, Psychology | 2008 |
Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235.
Topics: Amnesia; Animals; Avoidance Learning; Mice; Nootropic Agents; Piperazines; Pyrroles; Stereoisomerism; Structure-Activity Relationship | 2015 |